• Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation 

      Al Malki, Monzr M.; Bo-Subait, Stephanie; Logan, Brent; Olson, Janelle; Kou, Jianqun; ... more authors ( American Society of Clinical Oncology (ASCO) , 2025 , Article)
      PURPOSEAllogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for advanced hematologic malignancies. HSCT using human leukocyte antigen (HLA)-mismatched donors is historically associated with ...